0001104659-26-066401.txt : 20260527 0001104659-26-066401.hdr.sgml : 20260527 20260526174928 ACCESSION NUMBER: 0001104659-26-066401 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260527 DATE AS OF CHANGE: 20260526 EFFECTIVENESS DATE: 20260527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GridAI Technologies Corp. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 464993860 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-585168 FILM NUMBER: 261021381 BUSINESS ADDRESS: STREET 1: 433 PLAZA REAL STREET 2: SUITE 275 CITY: BOCA RATON STATE: FL BUSINESS PHONE: 561-589-7020 MAIL ADDRESS: STREET 1: 433 PLAZA REAL STREET 2: SUITE 275 CITY: BOCA RATON STATE: FL FORMER COMPANY: FORMER CONFORMED NAME: Entero Therapeutics, Inc. DATE OF NAME CHANGE: 20240516 FORMER COMPANY: FORMER CONFORMED NAME: First Wave BioPharma, Inc. DATE OF NAME CHANGE: 20210921 FORMER COMPANY: FORMER CONFORMED NAME: AzurRx BioPharma, Inc. DATE OF NAME CHANGE: 20141103 D 1 primary_doc.xml X0708 D LIVE 0001604191 GridAI Technologies Corp. 433 PLAZA REAL, SUITE 275 BOCA RATON FL FLORIDA 33432 561-589-7020 DELAWARE None Entero Therapeutics, Inc. First Wave BioPharma, Inc. AzurRx BioPharma, Inc. Corporation true JASON SAWYER 433 Plaza Real, Suite 275 BOCA RATON FL FLORIDA 33432 Executive Officer Director ED BORKOWSKI 433 Plaza Real, Suite 275 BOCA RATON FL FLORIDA 33432 Director MANPREET UPPAL 433 Plaza Real, Suite 275 BOCA RATON FL FLORIDA 33432 Director GEORDAN PURSGLOVE 433 Plaza Real, Suite 275 BOCA RATON FL FLORIDA 33432 Director JACK SYAGE 433 Plaza Real, Suite 275 BOCA RATON FL FLORIDA 33432 Director Pharmaceuticals Decline to Disclose 06b false 2026-05-11 false true true true false 0 5250000 5250000 0 20% of the gross proceeds will be paid to the Company at closing. The remaining 80% of the proceeds will be paid prior to the declaration by the SEC that the Registration Statement is effective. false 4 0 0 0 true Some of the proceeds may be used for general corporate purposes including the payment of salaries and other fees to those listed in Item 3. false GridAI Technologies Corp. /s/ Jason Sawyer Jason Sawyer Chief Executive Officer 2026-05-26